Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes

Summary

This is a randomized, double-blind, placebo-controlled parallel group study of HU6 and placebo in subjects who are overweight or obese with T2D. The study will be conducted in 4 stages.

Timeline

Start

2023-11-17

Primary completion

2025-02

Completion

2025-03

Outcome

Outcome not reported

Stopped: “The protocol was redirected by the FDA to another division and will be resubmitted at a future date.”

Drugs

Indications